94
Views
26
CrossRef citations to date
0
Altmetric
Original Research

A Belgian survey on the diagnosis of asthma–COPD overlap syndrome

, , , , , , , , , & show all
Pages 601-613 | Published online: 13 Feb 2017

References

  • AggarwalANGuptaDAgarwalRJindalSKComparison of the lower confidence limit to the fixed-percentage method for assessing airway obstruction in routine clinical practiceRespir Care201156111778178421605485
  • Global Initiative for AsthmaDiagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). A joint project of GINA and GOLD2015
  • Soler-CatalunaJJCosioBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol201248933133722341911
  • BarrechegurenMEsquinasCMiravitllesMThe asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challengesCurr Opin Pulm Med2015211747925405671
  • BatemanEDReddelHKvan Zyl-SmitRNAgustiAThe asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?Lancet Respir Med20153971972826255108
  • KiljanderTHelinTVenhoKJaakkolaALehtimakiLPrevalence of asthma-COPD overlap syndrome among primary care asthmatics with a smoking history: a cross-sectional studyNPJ Prim Care Respir Med2015251504726182124
  • MiravitllesMCalleMSoler-CatalunaJJClinical phenotypes of COPD: identification, definition and implications for guidelinesArch Bronconeumol2012483869822196477
  • MiravitllesMIndividually-tailored treatment of chronic obstructive pulmonary disease: a proposed changeArch Bronconeumol200945Suppl 5273420116759
  • SinDDMiravitllesMManninoDMWhat is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussionEur Respir J201648366467327338195
  • TashkinDPCelliBDecramerMBronchodilator responsiveness in patients with COPDEur Respir J200831474275018256071
  • SchleichFCorhayJLLouisRBlood eosinophil count to predict bronchial eosinophilic inflammation in COPDEur Respir J20164751562156426846827
  • CalverleyPPauwelsRVestboJCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet2003361935644945612583942
  • CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
  • CalverleyPMBoonsawatWCsekeZZhongNPetersonSOlssonHMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J200322691291914680078
  • PauwelsRALofdahlCGPostmaDSEffect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study GroupN Engl J Med199733720140514119358137
  • RabeKFAtienzaTMagyarPLarssonPJorupCLallooUGEffect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind studyLancet2006368953774475316935685
  • SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J2003211748112570112
  • TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
  • WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
  • WedzichaJABanerjiDChapmanKRIndacaterol-glycopyrronium versus salmeterol-fluticasone for COPDN Engl J Med2016374232222223427181606
  • ThoNVParkHYNakanoYAsthma-COPD overlap syndrome (ACOS): a diagnostic challengeRespirology201621341041826450153
  • LikertRA technique for the measurement of attitudesArch Psychol1932140155
  • KankaanrantaHHarjuTKilpelainenMDiagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finnish guidelinesBasic Clin Pharmacol Toxicol2015116429130725515181
  • MiravitllesMSoler-CatalunaJJCalleMA new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)Prim Care Respir J201322111712123443227
  • NagaiAGuidelines for the diagnosis and management of chronic obstructive pulmonary disease: 3rd editionNihon Rinsho2011691017291734 Japanese22073564
  • O’DonnellDEAaronSBourbeauJCanadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 updateCan Respir J200714Suppl B5B32B
  • KoblizekVChlumskyJZindrVChronic obstructive pulmonary disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented careBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub2013157218920123733084
  • AndersenHLampelaPNevanlinnaASaynajakangasOKeistinenTHigh hospital burden in overlap syndrome of asthma and COPDClin Respir J20137434234623362945
  • BrzostekDKokotMAsthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological studyPostepy Dermatol Alergol201431637237925610352
  • Gerhardsson de VerdierMAnderssonMKernDMZhouSTunceliOAsthma and chronic obstructive pulmonary disease overlap syndrome: doubled costs compared with patients with asthma aloneValue Health201518675976626409602
  • HardinMSilvermanEKBarrRGThe clinical features of the overlap between COPD and asthmaRespir Res20111212721951550
  • MenezesAMMontes de OcaMPerez-PadillaRIncreased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthmaChest2014145229730424114498
  • FuJJGibsonPGSimpsonJLMcDonaldVMLongitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndromeRespiration2014871637424029561
  • FuJJMcDonaldVMGibsonPGSimpsonJLSystemic inflammation in older adults with asthma-COPD overlap syndromeAllergy Asthma Immunol Res20146431632424991455
  • HaradaTYamasakiAFukushimaTCauses of death in patients with asthma and asthma-chronic obstructive pulmonary disease overlap syndromeInt J Chron Obstruct Pulmon Dis20151059560225834418
  • DingBEnstoneAAsthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insightsExpert Rev Respir Med201610336337126789845
  • JanssensWLiuYLiuDQuality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT(R))Respir Med201310791409141623714653
  • HasegawaKCamargoCAJrPrevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPDRespirology201621476176426699685
  • Alcazar-NavarreteBRomero-PalaciosPJRuiz-SanchoARuiz-RodriguezODiagnostic performance of the measurement of nitric oxide in exhaled air in the diagnosis of COPD phenotypesNitric Oxide201654677226916083
  • ChenFJHuangXYLiuYLLinGPXieCMImportance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPDInt J Chron Obstruct Pulmon Dis2016112385239027713629
  • TamadaTSugiuraHTakahashiTBiomarker-based detection of asthma-COPD overlap syndrome in COPD populationsInt J Chron Obstruct Pulmon Dis2015102169217626491283
  • LangePColakYIngebrigtsenTSVestboJMarottJLLong-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysisLancet Respir Med20164645446227061878
  • PostmaDSRabeKFThe asthma-COPD overlap syndromeN Engl J Med2015373131241124926398072
  • D’UrzoADonohueJFKardosPMiravitllesMPriceDA reevaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary diseaseExpert Opin Pharmacother201516121845186026194213
  • GillissenAHaidlPKhlhauflMKroegelKVoshaarTGessnerCThe pharmacological treatment of chronic obstructive pulmonary diseaseDtsch Arztebl Int20161131831131627215595
  • SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J200423569870215176682
  • Global Initiative for Chronic Obstructive Lung DiseaseGOLD Reports Available from: http://goldcopd.org/gold-reports/Accessed September 15, 2016
  • BrusselleGPriceDGruffydd-JonesKThe inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UKInt J Chron Obstruct Pulmon Dis2015102207221726527869
  • LieskerJJBathoornEPostmaDSVonkJMTimensWKerstjensHASputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPDRespir Med2011105121853186021802933
  • WatzHTetzlaffKWoutersEFBlood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialLancet Respir Med20164539039827066739